Business Due Diligence Report · Business News · Competition Laws in India · Compulsory Licensing in India · Freedom to Operate · Google Adwords · Indian Trade Marks Office · INDIAN TRADEMARK Registry OFFICE · Intellectual Property · Intellectual Property India · Intellectual Property strategy · IP due-diligence · IPR Funding · Patent Attorney at Law · Patent Attorney India · Patent Attorney USPTO · Patent Expert · Social Media Policies · Software Patent Application · Start ups · Trademark Filing Procedure in India · trademark infringement · Trademark Opposition and Opposition Procedure in India · Trademark Opposition in India · Trademark Prosecution of Indian Trademark Application · Venture Capital Funding · Venture Capital Investments

Company Registration Charges in India | Charges to Include Mortgage | Interest or Lien | Property or Assets of a Company | Registrar of Companies | ROC | Pledge of Movable Property | Registration of All charges | Registration of Pledge

Company Registration Charges in India | Charges to Include Mortgage | Interest or Lien | Property or Assets of a Company | Registrar of Companies | ROC | Pledge of Movable Property | Registration of All charges | Registration of Pledge

Bayer's Cancer Drug · Compulsory Licensing in India · generics medicine · India IP Law firm · Legal News · Natco Pharma · Nexavar · Patent Rights

Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India

India Allows Compulsory Licensing of Bayer The decision is likely to open up the field for the generics industry or force innovative companies to make drugs more affordable. But will it also affect innovation? BioSpectrum explores the two sides of the story The globally watched case related to an Indian pharma company's request to the… Continue reading Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India